ワシントンにおける大うつ病性障害の臨床試験
ワシントン内の拠点で、大うつ病性障害に関する21件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/10/01更新 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/25更新 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/24更新 · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/26更新 · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
被験者募集中
18歳〜65歳 · 全性別 · 2026/08/19更新 · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/14更新 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/10更新 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/06/15更新 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/01/20更新 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/29更新 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
被験者募集中第4相
18歳〜65歳 · 全性別 · 2025/01/23更新 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
被験者募集中
18歳〜64歳 · 全性別 · 2024/09/19更新 · NCT06005194ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。